tirzepatide surmount-1 weight loss percent 72 weeks results December Blog Post: Tirzepatide, Worth the Weight? SURMOUNT-1: Tirzepatide Drastically Reduces Weight

When transitioning from semaglutide to another diabetes medication, clinicians should anticipate overlapping drug effects for several weeks

How health services are going to fund these medications into the future is a source of major debate

Those with kidney disease, high blood pressure, or a heart condition should avoid high-dose IV vitamin therapy like the Myers Cocktail

Here is what the typical patient journey looks like: Additional Benefits of Tirzepatide Beyond Weight Loss One of the most compelling aspects of GLP-1/GIP weight loss therapy is that the benefits extend well beyond the number on the scale

PolyPeptide Group, acquired by Novo Holdings (Novo Nordisk's parent foundation) in 2022, occupies an interesting dual role as both an independent CDMO and a strategically affiliated supplier within the broader Novo Nordisk ecosystem